Alcon, a Novartis Company in Eyewear (World)

Alcon ranks second in the global contact lenses and solution market. It has established a strong foothold in North America and now aims to grow its presence in Asia Pacific and Western Europe. To do so, Alcon is continuously innovating, as recently seen with the latest multifocal version of its Dailies Total 1 contact lenses. Also, the company is looking at a spin off from Novartis to become an independent entity by 2019.

Euromonitor Internationals Alcon, a Novartis Company in Eyewear (World) Company Profile offers detailed strategic analysis of the companys business, examining its performance in the Eyewear industry. The report examines company shares by region and sector, product developments, market and distribution strategies, challenges from the competition and future prospects. Use it to understand opportunities and threats facing the business and the factors driving success.


Product coverage: Contact Lenses and Solutions, Spectacles.

Data coverage: market sizes (historic and forecasts), company shares, brand shares and distribution data.

Why buy this report?
* Get a detailed picture of the Eyewear market;
* Pinpoint growth sectors and identify factors driving change;
* Understand the competitive environment, the markets major players and leading brands;
* Use five-year forecasts to assess how the market is predicted to develop.


Alcon, a Novartis Company in Eyewear (World)
Euromonitor International
December 2017
Scope of the Report
Strategic Evaluation
Competitive Positioning
Market Assessment
MARKET ASSESSMENT
Geographic and Category Opportunities
Brand Strategy
Operations
Recommendations
Report Definitions

Alcon, a Novartis Company in Eyewear (World)

Alcon ranks second in the global contact lenses and solution market. It has established a strong foothold in North America and now aims to grow its presence in Asia Pacific

USD 572 View Report

Fill The Form For Sample Request

Note : * Kindly provide us with your company id and get the sample reports at the earliest.

There is no Reviews available